SINTX Technologies Announces Publication of Study to Reduce the Spread and Transfer of Coronavirus
June 24 2020 - 3:20PM
Business Wire
Silicon nitride demonstrates anti-viral
properties against SARS-CoV-2 and kills virus within minutes of
exposure.
SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the
“Company”), an original equipment manufacturer (OEM) ceramics
company focused on silicon nitride and its applications, today
announced positive testing results demonstrating the anti-viral
properties of its silicon nitride which may be useful in the
reduction of the spread of COVID-19. The study results demonstrated
that SINTX’s unique grade of silicon nitride inactivates the
SARS-CoV-2 virus within a minute after exposure, and has the
potential to decrease the risk of viral disease spread on
surfaces.
Studies have shown that coronavirus spreads between humans when
an infected person coughs or sneezes. Also, the virus can remain
active on a variety of commonly touched surfaces for hours to days.
SINTX believes that by incorporating its unique composition of
silicon nitride into products such as face masks, and personal
protective equipment, it is possible to manufacture surfaces that
inactivate viral particles, thereby limiting the spread of the
disease. SINTX envisions incorporating its silicon nitride into
high-contact surfaces such as medical equipment, screens,
countertops, and doorknobs in locations where viral persistence is
a concern, such as homes, casinos, and cruise ships.
“The study builds upon years of research toward understanding
the basic biochemistry of silicon nitride,” said Dr. Sonny Bal,
President, and CEO of SINTX. “The antiviral attributes of silicon
nitride are consistent with the known antibacterial behavior of
silicon nitride. The results with coronavirus inactivation are
likewise consistent with an earlier study that showed similar
inactivation of other viruses, including Influenza A and
Enterovirus, both of which cause human disease.”
“The study and testing results show promise toward developing a
new category of face masks for healthcare professionals and general
consumers,” said Bruce Lorange, Founder, and CEO, O2TODAY. “Face
masks used by healthcare workers today can capture virus particles,
but the virus can remain viable in the mask, even as long 7 days
after use. Inclusion of silicon nitride technology into the mask
may enhance personal safety while reducing the risk of disease
spread.”
“This antiviral discovery opens many new opportunities for
SINTX. In composites, coatings, and mixtures, silicon nitride has
maintained its antibacterial and osteogenic properties, even at
small fractions. We believe that incorporating our material into a
variety of commonly-touched surfaces will discourage viral spread,
and contribute to global health by reducing the risk of disease,”
Dr. Bal added.
The present study was done independently, with SINTX supplying
its silicon nitride for the testing. The complete data and study
can be downloaded at bioRxiv.
Additional tests are underway at several U.S. research centers to
further understand the isolation and optimization of the antiviral
properties of silicon nitride; those results will be shared as they
become available.
About SINTX Technologies, Inc.
SINTX Technologies is an OEM ceramics company that develops and
commercializes silicon nitride for medical and non-medical
applications. The core strength of SINTX Technologies is the
manufacturing, research, and development of silicon nitride
ceramics for external partners. The Company manufactures silicon
nitride material and components in its FDA registered and ISO 13485
certified facility. For more information on SINTX Technologies or
its silicon nitride material platform, please visit
www.sintx.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, as amended (PSLRA) that are subject to several risks and
uncertainties. Risks and uncertainties that may cause such
differences to include, among other things, that SINTX has not
developed any PPE products which incorporate the use of silicon
nitride, incorporation of silicon nitride into PPE may not be safe
or effective; the uncertainties inherent in research and
development, including the cost and time required to advance our
products to regulatory submission; market acceptance of our
products once cleared and commercialized; our ability to raise
additional funding and other competitive developments. Readers are
cautioned not to place undue reliance on the forward-looking
statements, which speak only as of the date on which they are made
and reflect management’s current estimates, projections,
expectations, and beliefs. There can be no assurance that any of
the anticipated results will occur on a timely basis or at all due
to certain risks and uncertainties, a discussion of which can be
found in SINTX’s Risk Factors disclosure in its Annual Report on
Form 10-K, filed with the Securities and Exchange Commission (SEC)
on March 26, 2020, and in SINTX’s other filings with the SEC. SINTX
disclaims any obligation to update any forward-looking statements.
SINTX undertakes no obligation to publicly revise or update the
forward-looking statements to reflect events or circumstances that
arise after the date of this report.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200624005791/en/
Business Inquiries for SINTX: SINTX Technologies
801.839.3502 IR@sintx.com
Media Inquiries for SINTX: Amanda Barry Account Manager,
Content and PR The Summit Group +1 509.554.8409
abarry@summitslc.com
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Mar 2024 to Apr 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Apr 2023 to Apr 2024